Product Specifications

Key Features

• Extended Release Profile: Provides prolonged therapeutic effects, making it ideal for managing chronic inflammatory states with fewer injections.

• Versatile Administration: Indicated for systemic therapy via deep intramuscular injection or localized treatment via intra-articular or soft tissue injection.

• Preservative-Free Option: This single-dose vial configuration is designed for immediate use, minimizing the risks associated with multi-dose contamination.

• Standard Potency: The 40 mg/mL concentration is the clinical standard for adult dosing in rheumatology and dermatology.

• Micronized Suspension: Formulated for smooth delivery through a range of needle gauges, ensuring consistent dosing.

Clinical Applications

• Rheumatology: Intra-articular injection for the short-term management of acute episodes or exacerbations of osteoarthritis, rheumatoid arthritis, and bursitis.

• Dermatology: Intralesional administration for conditions such as keloids, discoid lupus erythematosus, and localized hypertrophic lesions.

• Allergic States: Intramuscular use for control of severe or incapacitating allergic conditions (e.g., asthma, contact dermatitis) when conventional treatments fail.

• Endocrine Disorders: Used for primary or secondary adrenocortical insufficiency.

⚠️ Usage Note: Not for Intravenous (IV) use. This product is a suspension and must be shaken well before use to ensure a uniform dose.

⚠️ Safety: Do not inject into unstable joints. Frequent intra-articular injection may result in joint tissue damage. Avoid injection into an infected site.

⚠️ Side Effects: May cause localized skin depigmentation or atrophy at the injection site if not administered into the deep muscle or joint space correctly.